Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial

The APPLE COPD-ICON2 trial is a prospective 2×2 factorial, double-blinded proof-of-concept randomised controlled trial targeting patients with chronic obstructive pulmonary disease (COPD) without prior history of cardiovascular disease. The primary goal of this trial is to investigate if treatment w...

Full description

Bibliographic Details
Main Authors: Vijay Kunadian, Nina Wilson, Deborah D. Stocken, Hani Ali, Elaine McColl, Graham Burns, Nicola Howe, Andrew Fisher, Anthony De Soyza, Trial management group, Deborah Stocken, Sean Scott, Jared Thornton, Lesley Hall, Alexander von Wilamowitz-Moellendorff, Andrea Bell, Eva-Maria Holstein, Laura Robertson, Cath Brennand, Jaki Begum
Format: Article
Language:English
Published: European Respiratory Society 2019-08-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/5/3/00110-2019.full

Similar Items